Applied Dna Sciences Inc (NASDAQ:BNBX – Get Free Report) saw a significant growth in short interest in June. As of June 30th, there was short interest totaling 173,283 shares, a growth of 213.0% from the June 15th total of 55,360 shares. Approximately 2.6% of the shares of the stock are sold short. Based on an average daily trading volume, of 271,228 shares, the short-interest ratio is presently 0.6 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Applied Dna Sciences presently has a consensus rating of “Sell”.
Get Our Latest Analysis on BNBX
Applied Dna Sciences Trading Down 19.0%
Applied Dna Sciences (NASDAQ:BNBX – Get Free Report) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.68) EPS for the quarter. The business had revenue of $1.02 million during the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%.
Applied Dna Sciences Company Profile
Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.
Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.
Featured Stories
- Five stocks we like better than Applied Dna Sciences
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
